Management's guidance for FY25 suggests flat comparable sales and a 10.5% adjusted EBITDA margin, reflecting potential structural shifts. I maintain a Hold rating on ARHS stock due to its high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback